Jacob A. Orville, General Manager, Screening at EXACT SCIENCES CORP (EXAS), sold 5,000 shares at $80.00 ($400K) on 2023-05-10, disclosed to the SEC on 2023-05-12.
Scheduled sale ($400k) by General Manager, Screening under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EXAS | SELL | 2024-03-04 | $256K | — | Filing → |
| EXAS | SELL | 2024-02-28 | $214K | — | Filing → |
| EXAS | SELL | 2024-02-23 | $121K | — | Filing → |